← SynDRA
PALONOSETRON
SynDRA canonical compound SYN0022868 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | HTR3A |
| Mechanism of action | Serotonin receptor antagonist |
| Indication | nausea | vomiting |
| Disease area | gastroenterology |
All known targets
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR3A ANTAGONIST
- Serotonin 3a (5-HT3a) receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- KCNH2
- ADRA2C
- SLC6A4
- HRH1
- MUTYH
- NTHL1
- NR3C1
- NR1I2
- NPY1R
- NEIL1
- MLNR
- OPRK1
- MC4R
- MC3R
- MBD4
- MAOA
- OPRD1
- ADORA1
- KCND3
- PDE3A
- PDE4D
- PGR
- PTGS2
- SCN5A
- SLC29A1
- SLC6A2
- SLC6A3
- SMUG1
- TBXA2R
- TDG
- TDP1
- OPRM1
- HTR2C
- ADORA2A
- CHRM1
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRB1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Antiemetics
- Central Nervous System Agents
- Gastrointestinal Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Serotonin 5-HT3 Receptor Antagonists
- Serotonin Agents
- Serotonin Antagonists
- Serotonin 3 Receptor Antagonists
- Serotonin-3 Receptor Antagonist
ATC classes
- A04A · ANTIEMETICS AND ANTINAUSEANTS
Cross-references
Synonyms
- AKYNZEO
- ALOXI
- PALONOSETRON HYDROCHLORIDE
- POSFREA
- Posfrea
- (-)-Palonosetron
- palonosetron hydrochloride
- aloxi
- RS 25259-197
- palonosetron HCl
- (-)-palonosetron
- Palonosetron, (3as, 3s)-
- NSC-743769
- Aloxi
- Onicit
- Palonosetron [INN]
- Aloxi (TN)
- RS-25233-197
- RS-25259-197
- 5D06587D6R
- NSC 743769
- 2-Qhbiqo
- Palonosetronum
- CHEBI:85161
- RS 25233 198
- RS 25259 198
- RS-25259
- RefChem:56726
- DTXCID6028317
- A04AA05
- RS25259
- RS25233197
- RS25233198
- RS25259197
- RS25259198
- RS 25233197
- RS 25233198
- RS 25259197
Reported adverse events
- Constipation
- Dyspepsia
- Headache
- Hypersensitivity
- Asthenia
- Erythema
- Fatigue
Look up PALONOSETRON in the interactive SynDRA portal →